Literature DB >> 19339057

Time discrimination deficits in schizophrenia patients with first-rank (passivity) symptoms.

Flavie Waters1, Assen Jablensky.   

Abstract

Schizophrenia patients with first-rank (passivity) symptoms (FRS) report a loss of clear boundaries between the self and others and that their thoughts and actions are controlled by external forces. One of the more widely accepted explanatory models of FRS suggests a dysfunction in the 'forward model' system, whose role consists in predicting the sensory consequences of actions [Frith, C., 2006. The neural basis of hallucinations and delusions. Comptes Rendus Biologies 328, 169-175.]. There has been recent interest in the importance of timing precision underlying both the functioning of the forward model, and in processes contributing to the mechanisms of self-recognition [Haggard, P., Martin, F., Taylor-Clarke, M., Jeannerod, M., Franck, N., 2003. Awareness of action in schizophrenia. Neuroreport 14, 1081-1085.]. In the current study, we examined whether schizophrenia patients with FRS have a time perception impairment, using an auditory discrimination task requiring judgments of temporal intervals. Thirty-five schizophrenia patients (15 with, and 20 without, FRS), and 16 non-clinical controls completed the task. The results showed that patients with FRS experienced time differently by underestimating the duration of time intervals. Given the role of timing in shaping sensory awareness and in the formation of causal mental associations, a breakdown in timing mechanisms may affect the processes relating to the perceived control of actions and mental events, leading to disturbances of self-recognition in FRS.

Entities:  

Mesh:

Year:  2009        PMID: 19339057     DOI: 10.1016/j.psychres.2008.04.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  21 in total

1.  On the neurobiology of hallucinations.

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

2.  Mistiming of thought and perception predicts delusionality.

Authors:  Adam Bear; Rebecca G Fortgang; Michael V Bronstein; Tyrone D Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

3.  Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia.

Authors:  Michael Avissar; Shanghong Xie; Blair Vail; Javier Lopez-Calderon; Yuanjia Wang; Daniel C Javitt
Journal:  Schizophr Res       Date:  2017-07-11       Impact factor: 4.939

Review 4.  Timing as a window on cognition in schizophrenia.

Authors:  Ryan D Ward; Christoph Kellendonk; Eric R Kandel; Peter D Balsam
Journal:  Neuropharmacology       Date:  2011-04-21       Impact factor: 5.250

Review 5.  Sense of agency in the human brain.

Authors:  Patrick Haggard
Journal:  Nat Rev Neurosci       Date:  2017-03-02       Impact factor: 34.870

6.  Dexamphetamine effects on separate constructs in the rubber hand illusion test.

Authors:  Matthew A Albrecht; Mathew T Martin-Iverson; Greg Price; Joseph Lee; Rajan Iyyalol; Flavie Waters
Journal:  Psychopharmacology (Berl)       Date:  2011-03-23       Impact factor: 4.530

Review 7.  Explicit Time Deficit in Schizophrenia: Systematic Review and Meta-Analysis Indicate It Is Primary and Not Domain Specific.

Authors:  Valentina Ciullo; Gianfranco Spalletta; Carlo Caltagirone; Ricardo E Jorge; Federica Piras
Journal:  Schizophr Bull       Date:  2015-08-06       Impact factor: 9.306

Review 8.  First-rank symptoms in schizophrenia: reexamining mechanisms of self-recognition.

Authors:  Flavie A V Waters; Johanna C Badcock
Journal:  Schizophr Bull       Date:  2008-08-27       Impact factor: 9.306

Review 9.  Serotonergic hallucinogens as translational models relevant to schizophrenia.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-13       Impact factor: 5.176

Review 10.  Disturbance of intentionality: a phenomenological study of body-affecting first-rank symptoms in schizophrenia.

Authors:  Dusan Hirjak; Thiemo Breyer; Philipp Arthur Thomann; Thomas Fuchs
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.